Ph.D., Chief Scientific Officer, DiaCarta
Mike Powell is a highly recognized scientific and business leader with more than 25 year’s experience in R&D, technology, and business and corporate development. Mike has extensive knowledge and experience to in the fields of molecular diagnostic assay research and development, qPCR and other nucleic acid amplification technologies, and automated instrumentation platforms. Mike has published many research papers in leading scientific journals and holds more than 40 patents and patent-pending applications. He received his Ph.D. in medicinal organic chemistry from Loughborough University, Loughborough, UK and also pursued postdoctoral research and a teaching fellowship from University of Nottingham, Nottingham, UK. Mike was also a postdoctoral industrial research fellow at the University of Oxford, UK and was instrumental in developing the amperometric glucose sensing technology that was the basis of Medisense, Inc. which was acquired by Abbott Labs for $950M.
Clinical Dx Showcase: DiaCarta
DiaCarta is a translational genomics and personalized diagnostics company that provides highly sensitive and advanced technologies
Early Colorectal Cancer Detection Employing XNA Technology
This workshop will highlight the most recent developments in this field and how DiaCarta, Inc.’s proprietary technologies, products and services can provide such a solution for the global monitoring of human disease diagnosis, progression and therapy.